Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

The document summarizes important skin care topics for non-specialist doctors, including treatments for skin conditions and the management of skin diseases.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.